Pituitary

Papers
(The TQCC of Pituitary is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-10-01 to 2024-10-01.)
ArticleCitations
A Pituitary Society update to acromegaly management guidelines185
COVID-19 and the pituitary77
Isolated ACTH deficiency induced by cancer immunotherapy: a systematic review46
Descriptive epidemiology of craniopharyngiomas in the United States40
Skull base repair following endonasal pituitary and skull base tumour resection: a systematic review32
Clinical, biological, radiological, and pathological comparison of sparsely and densely granulated somatotroph adenomas: a single center experience from a cohort of 131 patients with acromegaly32
Managing pasireotide-associated hyperglycemia: a randomized, open-label, Phase IV study29
Pituitary society expert Delphi consensus: operative workflow in endoscopic transsphenoidal pituitary adenoma resection29
Glucocorticoid use in patients with adrenal insufficiency following administration of the COVID-19 vaccine: a pituitary society statement28
Mice with gene alterations in the GH and IGF family26
Prevalence of comorbidities and concomitant medication use in acromegaly: analysis of real-world data from the United States25
Consensus on criteria for acromegaly diagnosis and remission25
Glucocorticoid Withdrawal Syndrome following treatment of endogenous Cushing Syndrome24
Pre-operative serum inflammation-based scores in patients with pituitary adenomas22
Diabetes insipidus after endoscopic transsphenoidal surgery: multicenter experience and development of the SALT score21
Selective resection of cushing microadenoma guided by preoperative hybrid 18-fluoroethyl-L-tyrosine and 11-C-methionine PET/MRI20
Impact of intraoperative magnetic resonance imaging on gross total resection, extent of resection, and residual tumor volume in pituitary surgery: systematic review and meta-analysis19
Levoketoconazole improves clinical signs and symptoms and patient-reported outcomes in patients with Cushing’s syndrome19
Cephalocaudal tumor diameter is a predictor of diabetes insipidus after endoscopic transsphenoidal surgery for non-functioning pituitary adenoma18
Machine learning in predicting early remission in patients after surgical treatment of acromegaly: a multicenter study18
Diagnostic value of Knosp grade and modified Knosp grade for cavernous sinus invasion in pituitary adenomas: a systematic review and meta‐analysis18
Opioids and pituitary function: expert opinion17
Virtual magnetic resonance elastography has the feasibility to evaluate preoperative pituitary adenoma consistency17
Differences between immunotherapy-induced and primary hypophysitis—a multicenter retrospective study17
Cushing’s disease: adrenal steroidogenesis inhibitors17
Safety of growth hormone (GH) treatment in GH deficient children and adults treated for cancer and non-malignant intracranial tumors—a review of research and clinical practice17
Cardiovascular health and mortality in Cushing’s disease17
Immune profiling of pituitary tumors reveals variations in immune infiltration and checkpoint molecule expression16
Real-world experience with pasireotide-LAR in resistant acromegaly: a single center 1-year observation16
Impact of the diagnostic delay of acromegaly on bone health: data from a real life and long term follow-up experience16
The direct and indirect impact of the COVID-19 pandemic on the care of patients with pituitary disease: a cross sectional study16
Effects of adult growth hormone deficiency and replacement therapy on the cardiometabolic risk profile16
Pilot study to define criteria for Pituitary Tumors Centers of Excellence (PTCOE): results of an audit of leading international centers16
Corticotroph tumor progression during long-term therapy with osilodrostat in a patient with persistent Cushing’s disease16
Neural network modeling for prediction of recurrence, progression, and hormonal non-remission in patients following resection of functional pituitary adenomas16
Epidemiology of common and uncommon adult pituitary tumors in the U.S. according to the 2017 World Health Organization classification15
The NETting of pituitary adenoma: a gland illusion15
Levoketoconazole in the treatment of patients with endogenous Cushing’s syndrome: a double-blind, placebo-controlled, randomized withdrawal study (LOGICS)15
Complication avoidance protocols in endoscopic pituitary adenoma surgery: a retrospective cohort study in 514 patients15
Clinical profiles of silent corticotroph adenomas compared with silent gonadotroph adenomas after adopting the 2017 WHO pituitary classification system15
The microenvironment of pituitary adenomas: biological, clinical and therapeutical implications15
Determinants of skeletal fragility in acromegaly: a systematic review and meta-analysis14
Paltusotine, a novel oral once-daily nonpeptide SST2 receptor agonist, suppresses GH and IGF-1 in healthy volunteers14
Surgery is a safe, effective first-line treatment modality for noninvasive prolactinomas14
Endocrine disorders after primary gamma knife radiosurgery for pituitary adenomas: A systematic review and meta-analysis14
Treatment of Cushing’s syndrome with osilodrostat: practical applications of recent studies with case examples14
Normative data for pituitary size and volume in the general population between 50 and 66 years14
HOMA-IR in acromegaly: a systematic review and meta-analysis14
Prognostic value of nadir GH levels for long-term biochemical remission or recurrence in surgically treated acromegaly14
Extending lifespan by modulating the growth hormone/insulin-like growth factor-1 axis: coming of age14
Modern imaging in Cushing’s disease14
Gut microbiota in patients with newly diagnosed acromegaly: a pilot cross-sectional study13
Glucocorticoid receptor blockers13
Oral octreotide capsules for the treatment of acromegaly: comparison of 2 phase 3 trial results13
Long-term efficacy and safety of osilodrostat in Cushing’s disease: final results from a Phase II study with an optional extension phase (LINC 2)13
Prolactin immunoassay: does the high-dose hook effect still exist?13
Targeted therapies in the medical management of craniopharyngioma12
Predictive factors of postoperative diabetes insipidus in 333 patients undergoing transsphenoidal surgery for non-functioning pituitary adenoma12
Quality of life impairment after a diagnosis of Cushing’s syndrome12
AIP variant causing familial prolactinoma12
Novel approaches to bone comorbidity in Cushing’s disease: an update12
Implementation of functional imaging using 11C-methionine PET-CT co-registered with MRI for advanced surgical planning and decision making in prolactinoma surgery12
Genetics of Cushing’s disease: from the lab to clinical practice11
11C-methionine PET aids localization of microprolactinomas in patients with intolerance or resistance to dopamine agonist therapy11
Frailty does not preclude surgical success after endoscopic transsphenoidal surgery for pituitary adenomas11
Surgical outcomes of medically failed prolactinomas: a systematic review and meta-analysis10
Comparison between extended transsphenoidal and transcranial surgery for craniopharyngioma: focus on hypothalamic function and obesity10
Prevalence of Nelson’s syndrome after bilateral adrenalectomy in patients with cushing’s disease: a systematic review and meta-analysis10
Pituitary stalk interruption syndrome: phenotype, predictors, and pathophysiology of perinatal events10
How to rule out non-neoplastic hypercortisolemia (previously known as pseudo-cushing)10
HLA analysis of immune checkpoint inhibitor-induced and idiopathic isolated ACTH deficiency9
Refractory nonfunctioning pituitary adenomas9
Professor Rathke’s gift to neurosurgery: the cyst, its diagnosis, surgical management, and outcomes9
Pituitary Society Delphi Survey: An international perspective on endocrine management of patients undergoing transsphenoidal surgery for pituitary adenomas9
Rathke’s cleft cyst infections and pituitary abscesses: case series and review of the literature9
Typing of inflammatory lesions of the pituitary9
Anastrozole as add-on therapy for cabergoline-resistant prolactin-secreting pituitary adenomas: real-life experience in male patients9
The epidemiology and management patterns of pediatric pituitary tumors in the United States9
Proportion and predictors of Hypogonadism Recovery in Men with Macroprolactinomas treated with dopamine agonists9
Prevalence of clinical signs, symptoms and comorbidities at diagnosis of acromegaly: a systematic review in accordance with PRISMA guidelines9
Late Night Salivary Cortisol in the diagnosis of neoplastic hypercortisolism (including cyclic Cushing’s syndrome)9
Efficacy of temozolomide combined with capecitabine (CAPTEM) on refractory prolactinomas as assessed using an ex vivo 3D spheroid assay8
Management of prolactinomas in children and adolescents; which factors define the response to treatment?8
Increased risk of preneoplastic colonic lesions and colorectal carcinoma in acromegaly: multicenter case–control study8
Treatment and prognostic factors of pituicytoma: a single-center experience and comprehensive literature review8
Effects of oral macimorelin on copeptin and anterior pituitary hormones in healthy volunteers8
The role of endoscopic endonasal surgery in the management of prolactinomas based on their invasiveness into the cavernous sinus8
Clinical and radiographic assessment of peripheral joints in controlled acromegaly8
Machine learning as a clinical decision support tool for patients with acromegaly8
Reported outcomes in transsphenoidal surgery for pituitary adenomas: a systematic review8
Pregnancy outcomes in women receiving growth hormone replacement therapy enrolled in the NordiNet® International Outcome Study (IOS) and the American Norditropin® Studies: Web-Enabled Research (ANSWER8
Serum copeptin levels at day two after pituitary surgery and ratio to baseline predict postoperative central diabetes insipidus8
Outcomes of pituitary apoplexy: a comparison of microadenomas and macroadenomas8
Diagnosis and treatment outcomes of Cushing’s disease during pregnancy8
Radiological evolution of autograft fat used for skull base reconstruction after transsphenoidal surgery for pituitary adenomas8
A study on clinical outcomes of Rathke’s cleft cyst in patients managed conservatively8
0.038479804992676